Clinical observation of monoclonal fibrillary glomerulonephritis

Monoclonal gammopathy of renal significance is a condition caused by the proliferation of a clone of B-lymphocytes or plasma cells that does not reach the criteria required for the initiation of treatment for oncohematological indications, but is characterized by the secretion of nephrotoxic paraprotein. There are many morphological variants of this disease and their diagnosis requires the use of additional research methods. This article presents a clinical observation of a 54-year-old patient admitted to the nephrology department with nephrotic syndrome. According to the results of nephrobiopsy, the patient was diagnosed with monoclonal fibrillary glomerulonephritis. Additional examination of the patient did not reveal signs of lymphoproliferative disease.

1. Kyle R.A. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am. J. Med. 1978;64:814–826.

2. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014 Nov;15(12):e538-48. https://doi.org/10.1016/S1470-2045(14)70442-5

3. Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019 Jan;15(1):45-59. https://doi.org/10.1038/s41581-018-0077-4. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121. https://doi.org/10.1038/s41581-018-0102-7

4. Smirnov A.V., Dobronravov V.A., Khrabrova M.S. Clinical and morphological spectrum and long-term outcome in monoclonal gammopathy of renal significance: one center study. Nephrology (Saint-Petersburg). 2020;24(6):19-27. (In Russ). https://doi.org/10.36485/1561-6274-2020-24-6-19-27

5. Alonso-Titos J, Martínez-Esteban MD, López V, León M, Martin-Reyes G, Ruiz-Esteban P, Hernández D. Monoclonal gammopathy of renal significance: Early diagnosis is key. Nefrologia (Engl Ed). 2021 Sep-Oct;41(5):502-513. https://doi.org/10.1016/j.nefroe.2021.11.008

6. Zakharova E.V., Zykova A.S., Makarova T.A., Leonova E.S., Nikitina E.N., Stolyarevich E.S., Vorobieva O.A., Shutov E.V. Clinical and pathology characteristics of 197 patients with monoclonal gammopathies of renal significance and paraprotein-related kidney damage in malignant lymphoproliferative disorders. Nephrology and Dialysis. 2024;26(1):55-70. (In Russ). https://doi.org/10.28996/2618-9801-2024-1-55-70

7. Smirnov A.V., Dobronravov V.A., Khrabrova M.S., Afanasyev B.V. Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology. Oncohematology. 2020;15(2):49-60. (In Russ). https://doi.org/10.17650/1818-8346-2020-15-2-49-60

8. Fomina N.V., Utkina E.V. Monoclonal Gammapathy of Renal Significance: Morphological Variants of Lesion. The Russian Archives of Internal Medicine. 2021;11(5):325-334. (In Russ). https://doi.org/10.20514/2226-6704-2021-11-5-325-334

9. Gnanasampanthan S, Kousios A. Monoclonal gammopathies of renal significance. Clin Med (Lond). 2023 May;23(3):250-253. https://doi.org/https://doi.org/10.7861/clinmed.2023-RM3